Peter Maag Care Dx, Inc. (CDNA) insider trading activity

Peter Maag is of CareDx, Inc.. Currently has a direct ownership of 327,264 shares of CDNA, which is worth approximately $4.26 Million. The most recent transaction as insider was on Apr 29, 2024, when has been sold 13,281 shares (Common Stock) at a price of $5.27 per share, resulting in proceeds of $69,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K

4.65% 3M change

10.29% 12M change

Total Value Held $4.26 Million

Peter Maag Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 29 2024	BUY Exercise of conversion of derivative security	$69,990 $5.27 p/Share	13,281 Added 3.9%	327,264 Common Stock
Apr 04 2024	BUY Grant, award, or other acquisition	-	1,249 Added 0.4%	313,983 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	1,525 Added 0.49%	312,734 Common Stock
Oct 04 2023	BUY Grant, award, or other acquisition	-	1,552 Added 0.5%	311,209 Common Stock
Jul 13 2023	SELL Open market or private sale	$51,700 $10.34 p/Share	5,000 Reduced 1.59%	309,657 Common Stock
Jul 06 2023	BUY Grant, award, or other acquisition	-	1,521 Added 0.48%	314,657 Common Stock
Jun 28 2023	SELL Open market or private sale	$21,207 $8.72 p/Share	2,432 Reduced 0.77%	313,136 Common Stock

Jun 16 2023	BUY Grant, award, or other acquisition	-	18,844 Added 5.63%	315,568 Common Stock
Apr 11 2023	BUY Grant, award, or other acquisition	-	1,256 Added 0.42%	296,724 Common Stock
Feb 08 2023	SELL Open market or private sale	$51,486 $15.75 p/Share	3,269 Reduced 1.09%	295,468 Common Stock
Feb 02 2023	SELL Open market or private sale	$85,850 $17.17 p/Share	5,000 Reduced 1.65%	298,737 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	5,230 Added 1.69%	303,737 Common Stock
Jan 06 2023	BUY Grant, award, or other acquisition	-	834 Added 0.28%	298,507 Common Stock
Oct 04 2022	BUY Grant, award, or other acquisition	-	634 Added 0.21%	297,673 Common Stock
Aug 11 2022	SELL Open market or private sale	$499,400 $24.97 p/Share	20,000 Reduced 6.31%	297,039 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	487 Added 0.15%	317,039 Common Stock
Jun 16 2022	BUY Grant, award, or other acquisition	-	4,863 Added 1.51%	316,552 Common Stock
Apr 05 2022	SELL Open market or private sale	$389,000 $38.9 p/Share	10,000 Reduced 3.11%	311,689 Common Stock
Apr 05 2022	BUY Exercise of conversion of derivative security	$211,438 $21.25 p/Share	9,950 Added 3.0%	321,689 Common Stock
Mar 07 2022	SELL Open market or private sale	$332,000 $33.2 p/Share	10,000 Reduced 3.11%	311,739 Common Stock
Mar 07 2022	BUY Exercise of conversion of derivative security	$74,225 $18.3 p/Share	4,056 Added 1.24%	321,739 Common Stock
Feb 07 2022	SELL Open market or private sale	$420,600 $42.06 p/Share	10,000 Reduced 3.05%	317,683 Common Stock
Feb 03 2022	SELL Payment of exercise price or tax liability	$45,371 $40.08 p/Share	1,132 Reduced 0.34%	327,683 Common Stock
Jan 29 2022	SELL Payment of exercise price or tax liability	$131,589 $38.51 p/Share	3,417 Reduced 1.03%	328,815 Common Stock
Jan 19 2022	SELL Payment of exercise price or tax liability	$143,172 $37.46 p/Share	3,822 Reduced 1.14%	332,232 Common Stock

Also insider at

MIRO

Miromatrix Medical Inc. Healthcare

Peter Maag

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDNA shares.

Notify only if

Value

Insider Trading

Get notified when an Care Dx, Inc. insider buys or sells CDNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to CareDx, Inc.

Track Activities on CDNA

Account